top of page
Report Summary
Market Overview

Global Drug of Abuse Testing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Drug of Abuse Testing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Product Type (Analyzers (Immunoassay Analyzers, Chromatographic Devices, and Breath Analyzers), Rapid Testing Devices (Urine Testing Devices, and Oral Fluid Testing Devices), and Consumables), Sample Type (Saliva, Urine, Blood, and Other Sample Types), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)


Market Overview


The Global Drug of Abuse Testing Market was valued at USD 1,787.9 million in 2023 and is expected to reach USD 2,785.8 million by 2031 while growing at a CAGR of 5.7% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global drug of abuse testing market growth. Drug of abuse testing, also referred to as toxicology testing or drug screening, involves analyzing biological samples to identify illicit drugs or prescription medications taken inappropriately, serving various purposes such as medical diagnosis, forensic investigations, workplace screening, and monitoring individuals in drug rehabilitation programs.


The global rise in substance abuse, spanning opioids, marijuana, cocaine, amphetamines, and more, pairs with ongoing advancements in drug testing tech like immunoassays, chromatography, and rapid kits, fueling market growth. Yet, cost limitations, privacy worries, and legal hurdles might hinder its expansion.


Furthermore, the global drug of abuse testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Product Type Analysis


The Global Drug of Abuse Testing Market is segmented among Analyzers, Rapid Testing Devices, and Consumables, based on Product Type. In 2023, Consumables accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Sample Type Analysis


The Global Drug of Abuse Testing Market is segmented among Saliva, Urine, Blood, and Other Sample Types, based on Type. In 2023, Urine accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Drug of Abuse Testing Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share and is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Abbott Laboratories, Danaher Corporation (Beckman Coulter), LabCorp, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc., Randox Testing Services, United States Drug, Testing Laboratories Inc. (USDTL), Thermo Fisher Scientific Inc., Siemens Healthineers AG, and F. Hoffmann-La Roche Ltd.


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Drug of Abuse Testing Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Drug of Abuse Testing Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Drug of Abuse Testing Market Segmentation, By Product Type

  • Global Drug of Abuse Testing Market Share Analysis, By Product Type

  • Global Drug of Abuse Testing Market Growth Analysis, By Product Type

  • Global Drug of Abuse Testing Market Trends, By Product Type

o Analyzers

Ø Immunoassay Analyzers

Ø Chromatographic Devices

Ø Breath Analyzers

o Rapid Testing Devices

Ø Urine Testing Devices

Ø Oral Fluid Testing Devices

o Consumables

6. Global Drug of Abuse Testing Market Segmentation, By Sample Type

  • Global Drug of Abuse Testing Market Share Analysis, By Sample Type

  • Global Drug of Abuse Testing Market Growth Analysis, By Sample Type

  • Global Drug of Abuse Testing Market Trends, By Sample Type

o Saliva

o Urine

o Blood

o Other Sample Types

7. Global Drug of Abuse Testing Market Segmentation, By End User

  • Global Drug of Abuse Testing Market Share Analysis, By End User

  • Global Drug of Abuse Testing Market Growth Analysis, By End User

  • Global Drug of Abuse Testing Market Trends, By End User

o Hospitals

o Diagnostic Laboratories

o Forensic Laboratories

o Other End Users

8. Global Drug of Abuse Testing Market Segmentation, By Region

  • Global Drug of Abuse Testing Market Share Analysis, By Region

  • Global Drug of Abuse Testing Market Growth Analysis, By Region

  • Global Drug of Abuse Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

  • Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Danaher Corporation (Beckman Coulter)

  • LabCorp

  • Dragerwerk AG & Co. KGaA

  • Quest Diagnostics Inc.

  • Randox Testing Services

  • United States Drug Testing Laboratories Inc. (USDTL)

  • Thermo Fisher Scientific Inc.

  • Siemens Healthineers AG

  • F. Hoffmann-La Roche Ltd

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page